发明名称 PHARMACEUTICAL COMPOSITION CONTAINING SIBUTRAMINE AND A LIPASE INHIBITOR
摘要 A method for the treatment of obesity and associated co-morbid conditions in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula (I), including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a lipase inhibitor with the exception of orlistat; wherein the compound of formula (I) and the lipase inhibitor are administered simultaneously, separately or sequentially.
申请公布号 HU0201880(A3) 申请公布日期 2003.03.28
申请号 HU20020001880 申请日期 2000.06.16
申请人 ABBOTT GMBH & CO. KG, WIESBADEN 发明人
分类号 A61K45/00;A61K31/00;A61K31/135;A61K31/137;A61K45/06;A61P3/04 主分类号 A61K45/00
代理机构 代理人
主权项
地址